Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

About this update from Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Kanion Pharmaceutical Co. Ltd. Class A